R

Active Director Director DIN 08124523
DIN 08124523 First appointment May 2018 Primary industry Chemicals and Materials
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2018
Shareholding value •••• Premium profile

About Rajambal

Data last updated:

Rajambal is a Director at Einstek Pharma Private Limited (since 2018). The company operates in Chemicals and Materials. Einstek Pharma Private Limited reported revenue of ₹1.2 Lakh (FY 2025).

DIN 08124523
Primary Designation Director
Industry Chemicals and Materials
First Appointment 02 May 2018
Oldest Company Age 10 yrs
Largest company Einstek Pharma Private Limited · ₹1.2 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Einstek Pharma Private Limited U24230KA2016PTC085446
Director02 May 20182016₹1.2 Lakh (FY 2025)Active

Board colleagues of Rajambal

NameDINCompanyDesignation
Pachaiyappan Shanmugam07332906Einstek Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Einstek Pharma Private Limited
Premium access

Shareholding and investment profile for Rajambal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajambal

Rajambal currently holds 1 directorship: Einstek Pharma Private Limited (Director, since 02 May 2018, revenue ₹1.2 Lakh (FY 2025)).

Rajambal was first appointed on 02 May 2018 as Director at Einstek Pharma Private Limited.

The current boards of Rajambal's companies include Pachaiyappan Shanmugam (Einstek Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available